These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 20124477)

  • 1. Prolactin inhibits BCL6 expression in breast cancer through a Stat5a-dependent mechanism.
    Tran TH; Utama FE; Lin J; Yang N; Sjolund AB; Ryder A; Johnson KJ; Neilson LM; Liu C; Brill KL; Rosenberg AL; Witkiewicz AK; Rui H
    Cancer Res; 2010 Feb; 70(4):1711-21. PubMed ID: 20124477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal transducer and activator of transcription (STAT)-5A and STAT5B differentially regulate human mammary carcinoma cell behavior.
    Tang JZ; Zuo ZH; Kong XJ; Steiner M; Yin Z; Perry JK; Zhu T; Liu DX; Lobie PE
    Endocrinology; 2010 Jan; 151(1):43-55. PubMed ID: 19966185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of c-Myb during prolactin-induced signal transducer and activator of transcription 5a signaling in breast cancer cells.
    Fang F; Rycyzyn MA; Clevenger CV
    Endocrinology; 2009 Apr; 150(4):1597-606. PubMed ID: 19036881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression.
    Sato T; Tran TH; Peck AR; Girondo MA; Liu C; Goodman CR; Neilson LM; Freydin B; Chervoneva I; Hyslop T; Kovatich AJ; Hooke JA; Shriver CD; Fuchs SY; Rui H
    Oncogene; 2014 Apr; 33(17):2215-24. PubMed ID: 23708665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of Nuclear Localized Parathyroid Hormone-Related Protein in Primary Breast Cancer Predicts Poor Clinical Outcome and Correlates with Suppressed Stat5 Signaling.
    Tran TH; Utama FE; Sato T; Peck AR; Langenheim JF; Udhane SS; Sun Y; Liu C; Girondo MA; Kovatich AJ; Hooke JA; Shriver CD; Hu H; Palazzo JP; Bibbo M; Auer PW; Flister MJ; Hyslop T; Mitchell EP; Chervoneva I; Rui H
    Clin Cancer Res; 2018 Dec; 24(24):6355-6366. PubMed ID: 30097435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways.
    Neilson LM; Zhu J; Xie J; Malabarba MG; Sakamoto K; Wagner KU; Kirken RA; Rui H
    Mol Endocrinol; 2007 Sep; 21(9):2218-32. PubMed ID: 17550976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin signalling in the mouse hypothalamus is primarily mediated by signal transducer and activator of transcription factor 5b but not 5a.
    Yip SH; Eguchi R; Grattan DR; Bunn SJ
    J Neuroendocrinol; 2012 Dec; 24(12):1484-91. PubMed ID: 22775396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global profiling of prolactin-modulated transcripts in breast cancer in vivo.
    Sato T; Tran TH; Peck AR; Liu C; Ertel A; Lin J; Neilson LM; Rui H
    Mol Cancer; 2013 Jun; 12():59. PubMed ID: 23758962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin Drives a Dynamic STAT5A/HDAC6/HMGN2 Cis-Regulatory Landscape Exploitable in ER+ Breast Cancer.
    Craig JM; Turner TH; Harrell JC; Clevenger CV
    Endocrinology; 2021 May; 162(5):. PubMed ID: 33589921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat shock protein-90-alpha, a prolactin-STAT5 target gene identified in breast cancer cells, is involved in apoptosis regulation.
    Perotti C; Liu R; Parusel CT; Böcher N; Schultz J; Bork P; Pfitzner E; Groner B; Shemanko CS
    Breast Cancer Res; 2008; 10(6):R94. PubMed ID: 19014541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription factor signal transducer and activator of transcription 5 promotes growth of human prostate cancer cells in vivo.
    Dagvadorj A; Kirken RA; Leiby B; Karras J; Nevalainen MT
    Clin Cancer Res; 2008 Mar; 14(5):1317-24. PubMed ID: 18316550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism.
    Goodman CR; Sato T; Peck AR; Girondo MA; Yang N; Liu C; Yanac AF; Kovatich AJ; Hooke JA; Shriver CD; Mitchell EP; Hyslop T; Rui H
    Oncogene; 2016 Mar; 35(11):1373-85. PubMed ID: 26096934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transcriptional responsiveness of LKB1 to STAT-mediated signaling is differentially modulated by prolactin in human breast cancer cells.
    Linher-Melville K; Singh G
    BMC Cancer; 2014 Jun; 14():415. PubMed ID: 24913037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HDAC6 Deacetylates HMGN2 to Regulate Stat5a Activity and Breast Cancer Growth.
    Medler TR; Craig JM; Fiorillo AA; Feeney YB; Harrell JC; Clevenger CV
    Mol Cancer Res; 2016 Oct; 14(10):994-1008. PubMed ID: 27358110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic action of prolactin (PRL) and androgen on PRL-inducible protein gene expression in human breast cancer cells: a unique model for functional cooperation between signal transducer and activator of transcription-5 and androgen receptor.
    Carsol JL; Gingras S; Simard J
    Mol Endocrinol; 2002 Jul; 16(7):1696-710. PubMed ID: 12089361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue.
    Liu X; Robinson GW; Gouilleux F; Groner B; Hennighausen L
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8831-5. PubMed ID: 7568026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin induces SHP-2 association with Stat5, nuclear translocation, and binding to the beta-casein gene promoter in mammary cells.
    Chughtai N; Schimchowitsch S; Lebrun JJ; Ali S
    J Biol Chem; 2002 Aug; 277(34):31107-14. PubMed ID: 12060651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basal activation of transcription factor signal transducer and activator of transcription (Stat5) in nonpregnant mouse and human breast epithelium.
    Nevalainen MT; Xie J; Bubendorf L; Wagner KU; Rui H
    Mol Endocrinol; 2002 May; 16(5):1108-24. PubMed ID: 11981045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immunohistochemical approach to monitor the prolactin-induced activation of the JAK2/STAT5 pathway in pancreatic islets of Langerhans.
    Brelje TC; Svensson AM; Stout LE; Bhagroo NV; Sorenson RL
    J Histochem Cytochem; 2002 Mar; 50(3):365-83. PubMed ID: 11850439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional inhibition by Stat5. Differential activities at growth-related versus differentiation-specific promoters.
    Luo G; Yu-Lee L
    J Biol Chem; 1997 Oct; 272(43):26841-9. PubMed ID: 9341115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.